Robot companions may soothe cancer Patients' emotional turmoil

NCT ID NCT07745478

First seen Aug 04, 2026 · Last updated Aug 05, 2026 · Updated 1 time

Summary

This trial tests a supportive care program called E-MOTE, delivered by an AI-assisted robot during hospital stays and a mobile app after discharge, for women newly diagnosed with gynecologic cancer who are undergoing surgery. The program includes emotional assessments, empathetic conversations, and relaxation training, aiming to reduce psychological distress and depression while improving quality of life. Researchers will measure distress, depression, physical symptoms, stress, and quality of life in 120 participants to see if this technology-based approach offers meaningful emotional support during a challenging time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
E-MOTE emotional care program delivered via an AI-assisted robot and mobile platform
What this could lead to
If effective, this program could offer a practical, technology-based way to reduce emotional distress and improve quality of life for women undergoing gynecologic cancer surgery.
What could go wrong
This is a relatively small, early-stage trial, and the benefits may not be large or lasting. The program's success depends on patient engagement and the robot's ability to provide meaningful emotional support.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GYNECOLOGICAL CANCERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • National Taiwan University

    Taipei, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.